Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Evonik Will Set Up Investment Unit
by Marc S. Reisch
January 23, 2012
| A version of this story appeared in
Volume 90, Issue 4
Evonik Industries is establishing a venture capital unit that will invest up to $125 million over the next few years in start-up companies and venture capital funds around the globe. The firm says it will direct investments to innovative ideas that help globalize its businesses, lead to more efficient use of resources, and advance health and nutrition. Rather than being just a passive investor, the firm says, it will offer insight and technical expertise to companies in which it invests. Chemical firms including BASF, Dow Chemical, and DuPont already have corporate venture capital units.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X